Genomic Testing and Therapies for Breast Cancer in Clinical Practice

Authors
Publication date
1 January 2011
Publisher
American Society of Clinical Oncology
Doi
    View on PubMed

    Abstract

    Despite almost universal testing for HER2, many women with HER2-positive cancer may not receive trastuzumab. Fewer women received newer gene expression profile testing

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Sustaining member

      Harvard University - DASH

      redirect
      oaioai:dash.harvard.edu:1/3713534...
      Last time updated on 08/07/2018

      Crossref

      redirect
      oaiinfo:doi/10.1200%2Fjop.2011.00...
      Last time updated on 05/06/2019